RPC-913

German Biology

tagnone

6

6

Blood_test.jpg

null

h-transmutation.png h-biohazard.png h-mind-regression.png
Blood_test.jpg

Blood Taken from Subject-913-17

alpha-red.png

Registered Phenomena Code: 913

Object Class: Alpha - Red

Hazard Types: Transmutation Hazard, Bio-Hazard, Mind-Regression Hazard

Containment Protocols: RPC-913 is to be contained in a secure, sterile containment unit capable of maintaining a temperature of -5 °C. The containment unit must never reach temperatures lower than -15 °C or temperatures higher than 25 °C. The unit containing RPC-913 is to have a clearance level no lower than level 4. Any site or compound used to contain RPC-913 must have an armed security personnel as well as at least two MST units capable of responding to major threats to the site or compound's security. The containment unit and its immediate perimeter is to be under 24 hour surveillance and guard. See Site-███ and Site-074 for examples of proper containment standards. RPC-913 currently does not have clearance for experimentation, and as such, may not be accessed in any way with exception for the purposes of relocation or maintenance of the containment unit. All maintenance of RPC-913's containment unit must be approved by the site/compound director of security and at least two clearance level 4 personnel. Any transportation or relocation of RPC-913 must be approved by the site/compound director of security, the site/compound director, at least three clearance level 4 personnel, and the Regional Command Director: Director Ramalho.

Should the site or compound's security be compromised, the previous requirements for transportation are to be belayed, and RPC-913 is to immediately be moved to the nearest secure location. Once RPC-913 is secure, the regional director is to be informed of the security breach. Security personnel are to maintain the security of RPC-913 until a site capable of properly containing RPC-913 is chosen.

RPC-913 may not be ingested or injected into any personnel or persons. In the event that RPC-913 is consumed, either by injection or ingestion. The resulting instance is to be immediately terminated and the remains are to be cremated.

Following Incident 913-73, Alder drone surveillance is to be monitored for any potential GARD activity. Any GARD activity discovered is to be reported immediately.

Description: RPC-913 is the collective term given to several mutagenic compounds produced by the hostile GOI known as GARD. There are several different instances of RPC-913, each using a different combination of elements, chemical compounds and in later iterations, stem cells as key components. Each iteration of RPC-913 uses a specific compound referred to as compound-913. The compound has also seen variation in regards to the elements used as its foundation, but each instance uses a previously undiscovered element as a key building block in its structure. The origins of this element is currently unknown. It is also unclear whether the element is naturally occurring, manufactured, or anomalous in nature. However, due to its extraordinary effects, current theories on its nature lean towards it being manufactured by GARD or it being entirely anomalous.

When administered to living tissue, RPC-913 induces rapid mutation and expansion. The compound, when placed in a warm environment, such as a living organism or living tissue, rapidly breaks apart into its baser elements. Once broken apart, the unknown element within RPC-913 begins infiltrate the cells around it, gradually gravitating towards the nucleus. From there, the element behaves in a similar fashion to a virus, assuming control of the host's cell functions and, depending on the makeup of the RPC-913 iteration it was attached to, fundamentally alters the function of the host cell and its reproduction.

Frequently, especially among the earlier iterations of RPC-913, this simply leads to the cells becoming cancerous. Cancerous cells created by RPC-913 also display a much higher rate of reproduction and development. This heightened rate of development frequently causes subjects introduced to RPC-913 to develop advanced forms of cancer in a moderately short time span.

These iterations of RPC-913 are referred to in recovered GARD documents as "failures." Iterations given this status have an 85% or higher probability of causing subject expiration via organ failure or health complications, while at the same time not producing a "useable organism." Of the 20 iterations recovered, 16 are given this status. The four remaining compounds: RPC-913-6, RPC-913-14, RPC-913-17, and RPC-913-20, have been designated as "successful." These iterations, while still causing rapid mutation, either do not directly cause the subject to expire or have a mechanism that allows for the subject to sustain itself. The compounds and elements introduced to the undiscovered element alters the viral infection process of the element, allowing for a more controlled mutation rate. How the compounds introduced to the undiscovered element cause this alteration is currently unknown.1

The mutations created by these iterations can vary in severity and number depending on the subject. However, each compound has a select number of mutations that manifest at a 98% when administered. See Table 1 for a list of the observed mutations and their probability of manifesting. Present in nearly all iterations of RPC-913 is a substantial increase in size, bone density, and muscle mass. In addition, it should be noted that also present in every iteration is a marked decrease in mental stability. This mental deterioration compounds noticeably over extended periods of time in nearly all cases. Depression, psychosis, and paranoid schizophrenia are some of the most common complications to develop in subjects administered with RPC-913. In some cases, left untreated after an extended period of time, subjects have been observed losing all sense of sapience and entering a state of permanent psychosis. This phenomenon has also been observed in failed iterations of RPC-913, albeit occurring in a much shorter time span.

RPC-913 Compound Guaranteed Manifestations Probable Manifestations
RPC-913-6 "Jäger" Gigantism. Heightened hair growth. Osteopetrosis2 increased muscle mass Complete skeletal restructuring. Increased aggression. Carnivorism. Cancer
RPC-913-14 "Unbekannt" Heightened regeneration. Increased mass. Osteomalacia3. Mucus production. Cancer Gigantism, Loss of form. Schizophrenia.
RPC-913-17 "Habicht" Hollow bones. Additional set of appendages. Feathers Loss or restructuring of hands. Skeletal restructuring of feet and legs. Cancer
RPC-913-20 "Spinne" Additional appendages. Poison production. Chitin. Heightened hair growth. Additional eyes. Spinnerets and web production. Cancer

It should be noted that while these symptoms are quite common, they are not guaranteed nor untreatable. Notable instances have been recorded where subjects experienced limited or even no mental degradation. In addition, proper treatment of developing symptoms have been observed mitigating and even undoing their impact. More observation is required to properly determine the full extent of RPC-913's impact.

Due to the incomplete nature of RPC-913, subjects administered with RPC-913 have an extremely limited lifespan, even when administered with a "successful" iteration. The undiscovered element within RPC-913 does not stop the mutation process once administered. The element reproduces itself at a steady to rapid rate until every cell within the organism or tissue sample is undergoing a mutagenic process. Eventually, a mutation will cause cell death. Without a increased rate of cell regeneration, the occurrence of cell death will compound rapidly, resulting in catastrophic failure and expiration.

A notable exception is RPC-913-14, as the compound produces a heightened rate of regeneration. However, the affects RPC-913-14 has on the subject's mental state is much greater than other iterations, causing subjects administered with RPC-913-14 to frequently become suicidal.

It is clear from each iteration of RPC-913 that GARD scientist have attempted to mitigate the notable limitations of RPC-913, as every subsequent iteration has shown a reduced rate of mutation. It is theorized that with enough time, resources and left unhindered, an organization could perfect RPC-913 into a highly effective and potent weapon.4

Discovery: RPC-913 samples were provided to The Authority by the the German Agency known as Bundesokkultabteilung(The Federal Occult Agency) or The FOA. However, the first instance of a subject who had undergone RPC-913 mutation occurred during World War II in 1944, where Allied forces encountered an unidentified enemy force. With notable casualties, allied forces were successfully able to terminate the subject. Later in the campaign. RAVAFF forces located the source of this threat, a well hidden GARD research facility. The facility was taken via a joint RAVAFF and IOA resistance (Imperial Occult Agency, the precursor of the current FOA) operation. GARD forces were unable to detect allied forces before the raid, and as such, were taken completely by surprise. This prevented them from properly destroying critical research, resulting in the first acquisition of RPC-913 samples.

Addendum: Unknown Compound Discovery:

On December 17th, 2017, FOA director Johan ████████ contacted the Authority with information regarding the unknown compound found in RPC-913. The following is the email sent.

The following is the GARD ritual sent by the FOA. It is unclear where this ritual originated from, but it is currently theorized that the Children of Nihil may be involved. Investigation is ongoing.

Addendum: Acquisition and Retention: While GARD was largely dissolved in the aftermath of WWII, scattered cells still remain in operation throughout the modern world. It is clear that GARD has great interest in RPC-XXX, as several GARD cells were discovered to be in possession of RPC-913 samples. These samples are notably more advanced than those recovered during WWII, implying that GARD is actively working on creating and/or improving RPC-XXX. In addition, several GARD raids have occurred in sites containing samples of RPC-913. Nearly all attempts have ultimately failed in recovering any RPC-XXX samples.6 However, these raids pose significant risk to the Authority and the containment of not just RPC-913, but several other anomalies that may be housed in or near sites containing samples of RPC-913.

It is not believed that GARD has the resources required to create new RPC-913 samples. However, it is possible that GARD does have the resources necessary to improve upon any samples they may currently have. This has proven to be enough of a concern to both the Global Directors and the German Federal Chancellery to warrant cooperation against this threat. The Hamburg Agreement, signed in 2004 at Site-088,7 stipulates that the FOA is responsible for locating and recovering any samples of RPC-913 from GARD forces. Meanwhile, the RPC Authority is responsible for the containment and protection of any and all recovered RPC-913 samples. In addition, as part of an intel sharing scheme, The Authority will have limited assess to the FOA's surveillance program and their Adler drones.8

It is worth noting that The FOA have proven themselves extremely effective in this endeavor in particular, with reported combat performance being notably higher than in other operations. When inquiries were made regarding this marked increase in performance, FOA leadership only remarked that it was "personal." No further detail was given upon further questioning.

Currently, the FOA have successfully recovered 17 samples of RPC-913 from GARD.

Addendum: Incident 913-73: On December 14, 2002, a train station in Munich was attacked with chemical weapons using an unknown chemical agent. The attack killed 6 and injured 32 bystanders. The injured showed signs of severe mutagenic exposure, rapidly mutating shortly after the attack. Once the attack was believed to be anomalous in nature, the FOA sent VOSK forces to secure the area. The Authority was also called to further assist in containing the disaster. Several MST teams were sent to help assist VOSK forces and the area was quickly secured. A further 6 injured bystanders had to be terminated due to irreparable damage caused by the mutagenic process. Class-A amnestics and extensive media censorship were required to ensure containment and secrecy, which proved costly for both the Authority and the FOA.

The FOA investigation following the incident revealed that GARD was responsible for the incident, and that the unknown chemical used in the attack was a failed iteration of RPC-913. It was also revealed that GARD received assistance from The Church of Malthus for the attack. The perpetrators of the attack were quickly captured by the FOA. Unfortunately, no further information could be obtained from them, as they were soon executed by FOA forces following the revealing of the prior information.

This incident, as well as the prospect of GARD and potentially the Church of Malthus using RPC-913 for the purposes of chemical terrorism directly contributed to the creation of The Hamburg Agreement, as well as significantly influenced the FOA's later decision to the join The Operation Dawn Initiative in 2008.

Addendum: Recovered Experiment Logs:

The following are selected excerpts of experiment logs recovered from GARD facilities. It is through these logs that most of the information regarding RPC-913 was discovered. It is also the reason why experimentation with RPC-913 is currently prohibited.

« RPC-912 | RPC-913 | RPC-914 »

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License